Effect of normobaric and hyperbaric hyperoxia... (2025 study) Skip to main content
RCT Diving Hyperb Med 2025

Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial

D'hoore L, Germonpré P, Rinia B, Caeyers L, Stevens N, Balestra C, Diving Hyperb Med, 2025

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

The researchers randomly assigned 101 people with Long COVID to one of four groups that each had 10 sessions of breathing oxygen or air inside a pressure chamber, then compared symptoms, walking and thinking tests before and after.

What They Found

In this randomised, double-blind, placebo-controlled trial of 101 Long COVID patients, no significant differences in symptoms, functional scores or cognitive performance were found between any of the four groups after 10 chamber sessions. The groups were 100% oxygen at 2.5 atmospheres absolute, 40% oxygen at 2.5 atmospheres absolute, 100% oxygen at 1 atmosphere absolute, and 21% oxygen at 1 atmosphere absolute (the placebo group). Responses were highly variable, and some patients in the placebo group reported a significant improvement in well-being, but this was not reflected in any objective outcome score. No subgroup of patients responded better to any of the treatments.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract reports only 10 sessions and a three-month telephone follow-up, and it describes improvements in the placebo group as highly variable, so the findings apply only to this dose, schedule and patient group.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type RCT
Category Neurological
Source Pubmed
PubMed ID 40544138
Year Published 2025
Journal Diving Hyperb Med
MeSH Terms Humans; Hyperbaric Oxygenation; Male; Female; COVID-19; Middle Aged; Prospective Studies; Double-Blind Method; Quality of Life; Adult; Cognition; Aged; Treatment Outcome; Walk Test; Post-Acute COVID-19 Syndrome

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology